Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objective: To ascertain whether vaccination with L-BLP25 induces a MUC1-specific T-cell response in subjects with either: Chemotherapy-naïve, slowly progressive, asymptomatic MM with rising (at least 10%) M-protein concentrations displayed on 2 occasions separated by an interval of at least 4 weeks, within the last 18 months, or Stage II or III MM who have experienced a treatment-free interval of at least 3 months with a stable response/plateau phase following anti-tumor therapy.
Critère d'inclusion
- Chemotherapy-naive slowly progressive asymptomatic multiple myeloma with rising (at least 10%) M-protein concentration displayed on two occasions separated by an
- interval of at least 4 weeks within the last 18 months, or,Stage II or III multiple myeloma who have experienced a treatment-free interval of at least 3 months with a stable response/plateau phase following anti-tumor therapy